What are the benefits of statin therapy for individuals with diabetes aged 40 to 75?
Trials using moderate-intensity statin therapy have demonstrated significant benefit in individuals with diabetes aged 40 to 75, reducing major cardiovascular events by 8.5% over 3.8 years. High-intensity statins can provide greater ASCVD risk reduction than moderate-intensity statins or placebo, and so maximally tolerated statin therapy should be administered to these individuals. Non-statin therapies may also be recommended according to the 2018 cholesterol guidelines.